O4386
L -鸟氨酸 单盐酸盐
≥99%, BioXtra
别名:
(S)-2,5-二氨基戊酸 单盐酸盐
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C5H12N2O2 · HCl
化学文摘社编号:
分子量:
168.62
NACRES:
NA.26
PubChem Substance ID:
UNSPSC Code:
12352209
EC Number:
221-678-6
MDL number:
Beilstein/REAXYS Number:
3625847
产品名称
L -鸟氨酸 单盐酸盐, BioXtra, ≥99%
product line
BioXtra
Quality Level
assay
≥99%
form
powder
impurities
ammonia- and citrulline-free, essentially free, ≤0.005% Phosphorus (P), ≤0.1% Insoluble matter
ign. residue
≤0.1%
color
white
solubility
H2O: 1 M at 20 °C, clear, faintly yellow
anion traces
sulfate (SO42-): ≤0.05%
cation traces
Al: ≤0.0005%, Ca: ≤0.005%, Cu: ≤0.0005%, Fe: ≤0.0005%, K: ≤0.005%, Mg: ≤0.0005%, NH4+: ≤0.05%, Na: ≤0.005%, Pb: ≤0.001%, Zn: ≤0.0005%
SMILES string
Cl.NCCC[C@H](N)C(O)=O
InChI
1S/C5H12N2O2.ClH/c6-3-1-2-4(7)5(8)9;/h4H,1-3,6-7H2,(H,8,9);1H/t4-;/m0./s1
InChI key
GGTYBZJRPHEQDG-WCCKRBBISA-N
Biochem/physiol Actions
L-Ornithine is a not encoded by DNA. It is a free amino acid but do not participate in the protein synthesis. It is formed by the action of the enzyme arginase on L-arginine in the process of forming urea. It is implicated in the reduction of blood ammonia level and improves the efficiency of energy production to cause ammonia detoxification. L-ornithine promotes the release of growth hormone by triggering the pituitary gland.
Other Notes
精氨酸通过精氨酸酶降解所得产物
Still not finding the right product?
Explore all of our products under L -鸟氨酸 单盐酸盐
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
The effect of L-ornithine hydrochloride ingestion on performance during incremental exhaustive ergometer bicycle exercise and ammonia metabolism during and after exercise
Demura S, et al.
European Journal of Clinical Nutrition, 64(10), 1166-1171 (2010)
L-ornithine supplementation attenuates physical fatigue in healthy volunteers by modulating lipid and amino acid metabolism
Sugino T, et al.
Nutrition Research (New York, N.Y.), 28(11), 738-743 (2008)
Sherry Dadsetan et al.
Biochemical pharmacology, 85(1), 115-123 (2012-10-30)
Combined administration of ornithine and phenylacetate (OP) is proposed as a novel treatment of hyperammonemia and hepatic encephalopathy. Ornithine is believed to increase ammonia fixation into glutamine in muscle tissue and glutamine is subsequently thought to react with phenylacetate forming
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| O4386-25G | 04061833612415 |
| O4386-100G | 04061833612408 |